Literature DB >> 21453382

Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma.

I Akagi1, M Miyashita, O Ishibashi, T Mishima, K Kikuchi, H Makino, T Nomura, N Hagiwara, E Uchida, T Takizawa.   

Abstract

In spite of the undisputed importance of altered expression patterns of microRNAs (miRNAs) in various cancers, there is little information on the clinicopathologic significance of cancer-related miRNAs (MIR21, MIR143, MIR144, MIR145, and MIR205) in esophageal squamous cell carcinoma (ESCC). We examined the expression levels of the precursor and mature miRNA genes in ESCC using real-time polymerase chain reaction (PCR). We also investigated the mRNA expression levels of processing elements (RNASEN, DGCR8, and DICER1) that participate in miRNA-biogenesis pathway. Furthermore, we analyzed the relationships between the expression levels of these five miRNAs and the clinicopathologic parameters of ESCC patients. The expression levels of mature MIR21 and mature MIR145 were higher in ESCC than those in normal epithelium (P < 0.05). The mature/pre ratio of MIR21 in ESCC was higher than that in normal epithelium (P < 0.05). With regard to miRNA-processing elements, the expression level of RNASEN was higher in ESCC than in normal epithelium (P < 0.05). Furthermore, altered expression of these miRNAs was related to the clinicopathologic features of ESCC patients. The high expression of mature MIR21 and mature MIR205 was associated with lymph node positivity in ESCC patients (P < 0.05). The high levels of expression of mature MIR143 and mature MIR145 were associated with recurrence of metastasis in ESCC patients (P < 0.05). The findings may imply that miRNA biogenesis is aberrantly accelerated in ESCC. Analysis of the expression levels of miRNAs should provide useful information for evaluation of the staging, prognosis, and treatment of ESCC patients.
© 2011 Copyright the Authors. Journal compilation © 2011, Wiley Periodicals, Inc. and the International Society for Diseases of the Esophagus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453382     DOI: 10.1111/j.1442-2050.2011.01177.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  22 in total

1.  Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.

Authors:  Ebru Esin Yoruker; Fatma Aydoğan; Uğur Gezer; Pinar Saip; Nejat Dalay
Journal:  Mol Clin Oncol       Date:  2015-05-13

2.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

Review 3.  The role of microRNAs in cancers of the upper gastrointestinal tract.

Authors:  Shumei Song; Jaffer A Ajani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

Review 4.  Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

Authors:  Norihisa Uemura; Tadashi Kondo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.

Authors:  Anna Agnieszka Klimczak-Bitner; Radzisław Kordek; Jan Bitner; Jacek Musiał; Janusz Szemraj
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

6.  Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis.

Authors:  Daniela Di Girolamo; Raffaele Ambrosio; Maria A De Stefano; Giuseppina Mancino; Tommaso Porcelli; Cristina Luongo; Emery Di Cicco; Giulia Scalia; Luigi Del Vecchio; Annamaria Colao; Andrzej A Dlugosz; Caterina Missero; Domenico Salvatore; Monica Dentice
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

Review 7.  MicroRNA involvement in esophageal carcinogenesis.

Authors:  Stefan David; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2011-10-10       Impact factor: 5.547

8.  DGCR8 is essential for tumor progression following PTEN loss in the prostate.

Authors:  Cassandra D Belair; Alireza Paikari; Felix Moltzahn; Archana Shenoy; Christina Yau; Marc Dall'Era; Jeff Simko; Christopher Benz; Robert Blelloch
Journal:  EMBO Rep       Date:  2015-07-23       Impact factor: 8.807

9.  Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma.

Authors:  Ren Zhang; Xiaonan Chen; Shengjie Zhang; Xueyan Zhang; Tong Li; Zhicai Liu; Jinwu Wang; Wenqiao Zang; Yuanyuan Wang; Yuwen Du; Guoqiang Zhao
Journal:  Dig Dis Sci       Date:  2014-12-06       Impact factor: 3.199

10.  Low expression of microRNA-202 is associated with the metastasis of esophageal squamous cell carcinoma.

Authors:  Guoliang Ma; Fengmei Zhang; Xueguang Dong; Xiaoli Wang; Yuguo Ren
Journal:  Exp Ther Med       Date:  2016-01-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.